ABSTRACT
Cerebral malaria (CM) is a severe clinical complication of Plasmodium falciparum malaria infection and is characterized by a high fatality rate and neurological damage. Sequestration of parasite-infected red blood cells in brain microvasculature utilizes host- and parasite-derived adhesion molecules and is an important factor in the development of CM. ICAM-1, an alternatively spliced adhesion molecule, is believed to be critical on endothelial cells for infected red blood cell sequestration in CM. Using ICAM-1 mutant mice, we found that the full-length ICAM-1 isoform is not required for development of murine experimental CM (ECM) and that ECM phenotype varies with the combination of ICAM-1 isoforms expressed. Furthermore, we observed development of ECM in transgenic mice expressing ICAM-1 only on leukocytes, indicating that endothelial cell expression of this adhesion molecule is not required for disease pathogenesis. We propose that ICAM-1-dependent cellular aggregation, independent of ICAM-1 expression on the cerebral microvasculature, contributes to ECM.
Subject(s)
Brain , Cerebrovascular Circulation , Intercellular Adhesion Molecule-1/biosynthesis , Malaria, Cerebral/metabolism , Microcirculation , Plasmodium falciparum/metabolism , Alternative Splicing/genetics , Animals , Brain/blood supply , Brain/parasitology , Brain/pathology , Disease Models, Animal , Gene Expression Regulation , Intercellular Adhesion Molecule-1/genetics , Malaria, Cerebral/genetics , Malaria, Cerebral/pathology , Malaria, Cerebral/physiopathology , Mice , Mice, Transgenic , Protein Isoforms/biosynthesis , Protein Isoforms/geneticsABSTRACT
Cerebral malaria (CM) is the most severe manifestation of clinical malaria syndromes and has a high fatality rate especially in the developing world. Recent studies demonstrated that C5(-/-) mice are resistant to experimental CM (ECM) and that protection was due to the inability to form the membrane attack complex. Unexpectedly, we observed that C4(-/-) and factor B(-/-) mice were fully susceptible to disease, indicating that activation of the classical or alternative pathways is not required for ECM. C3(-/-) mice were also susceptible to ECM, indicating that the canonical C5 convertases are not required for ECM development and progression. Abrogation of ECM by treatment with anti-C9 antibody and detection of C5a in serum of C3(-/-) mice confirmed that C5 activation occurs in ECM independent of C5 convertases. Our data indicate that activation of C5 in ECM likely occurs via coagulation enzymes of the extrinsic protease pathway.
Subject(s)
Complement C3-C5 Convertases/metabolism , Malaria, Cerebral/immunology , Malaria, Cerebral/metabolism , Animals , Complement Activation/genetics , Complement Activation/physiology , Complement C3/genetics , Complement C3/metabolism , Complement C3-C5 Convertases/genetics , Complement C4/genetics , Complement C4/metabolism , Complement Factor B/genetics , Complement Factor B/metabolism , Malaria, Cerebral/genetics , Mice , Mice, Inbred BALB C , Mice, Knockout , Plasmodium berghei/immunology , Plasmodium berghei/pathogenicityABSTRACT
Cerebral malaria is the most severe complication of Plasmodium falciparum infection and accounts for a large number of malaria fatalities worldwide. Recent studies demonstrated that C5(-/-) mice are resistant to experimental cerebral malaria (ECM) and suggested that protection was due to loss of C5a-induced inflammation. Surprisingly, we observed that C5aR(-/-) mice were fully susceptible to disease, indicating that C5a is not required for ECM. C3aR(-/-) and C3aR(-/-) × C5aR(-/-) mice were equally susceptible to ECM as were wild-type mice, indicating that neither complement anaphylatoxin receptor is critical for ECM development. In contrast, C9 deposition in the brains of mice with ECM suggested an important role for the terminal complement pathway. Treatment with anti-C9 Ab significantly increased survival time and reduced mortality in ECM. Our data indicate that protection from ECM in C5(-/-) mice is mediated through inhibition of membrane attack complex formation and not through C5a-induced inflammation.